[HIV-associated Kaposi sarcoma in the head and neck area: a clinical, morphologic and therapeutic review]

Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

[HIV-associated Kaposi sarcoma in the head and neck area: a clinical, morphologic and therapeutic review]

Laryngorhinootologie. 1993 Oct;72(10):478-84. Unique Identifier : AIDSLINE MED/94092278
Riederer A; Zietz C; Held M; Klinik und Poliklinik fur HNO-Kranke,; Ludwig-Maximilians-Universitat Munchen.

Abstract: Since 1987 233 HIV-infected patients have been treated at the Department of Otorhinolaryngology, Head and Neck Surgery of the Ludwig-Maximilians-University of Munich. 70% of these patients had advanced immunodeficiency disease (ARC and AIDS). 46 presented a Kaposi's sarcoma (KS) in the head and neck region. 91% were homosexual men. KS was most often located in the mouth (67%), oropharynx (65%) and skin (39.1%), while the larynx (10.9%), hypopharynx (8.7%), lymph nodes (6.5%) and nasopharynx (4.3%) were rarely involved. In 15 patients, a KS of the head and neck region was the initial symptom for the HIV-infection. Although the clinical features of this disease are typical, histological examination is required because differential diagnosis can show other rare diseases, such as bacillary angiomatosis, which are easily cured. The morphology of early plain or elevated KS exhibits more irregular vascular components while the nodular KS is dominated by sarcomatous cell lines. Immunohistochemical studies with antibodies to viral components revealed no reactivity to HIV-, HPV-, HSV-, EBV- and CMV-antigens. The best local treatment proved to be CO2- or ND:YAG-laser therapy. Cutaneous lesions were treated with camouflage or by fractionated radiotherapy. Advanced disease showed best response to systemic chemotherapy. Despite the advanced stage of immunodeficiency syndrome, an adequate local or systemic therapy can obviously improve the quality of life in HIV-infected patients.

Keywords: Adult Chemotherapy, Adjuvant Combined Modality Therapy Diagnostic Imaging Doxorubicin/ADMINISTRATION & DOSAGE English Abstract Head and Neck Neoplasms/DRUG THERAPY/*PATHOLOGY/SURGERY Human HIV Infections/DRUG THERAPY/*PATHOLOGY/SURGERY Laryngoscopy Laser Surgery Male Middle Age Mouth Mucosa/PATHOLOGY Skin/PATHOLOGY JOURNAL ARTICLE
940430
M9440853

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .